Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 10, Pages e003476
Publisher
BMJ
Online
2021-10-02
DOI
10.1136/jitc-2021-003476
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- CReSCENT: CanceR Single Cell ExpressioN Toolkit
- (2020) Suluxan Mohanraj et al. NUCLEIC ACIDS RESEARCH
- LBA40 Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial
- (2020) L. Zuur et al. ANNALS OF ONCOLOGY
- Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
- (2020) Jonathan D. Schoenfeld et al. JAMA Oncology
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
- (2019) Yoko Tsukita et al. Molecular Cancer
- Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
- (2019) R. Charles Coombes et al. CLINICAL CANCER RESEARCH
- Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
- (2019) Jill M. Brooks et al. CLINICAL CANCER RESEARCH
- Immunotherapy for head and neck cancer: Recent advances and future directions
- (2019) John D. Cramer et al. ORAL ONCOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- LBA8_PRKEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
- (2018) B Burtness et al. ANNALS OF ONCOLOGY
- Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
- (2018) M Oliva et al. ANNALS OF ONCOLOGY
- TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
- (2017) Yemsratch T. Akalu et al. IMMUNOLOGICAL REVIEWS
- Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
- (2017) Andreas Pircher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis
- (2017) Neil M. Woody et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment
- (2016) Stefan Hartmann et al. CLINICAL CANCER RESEARCH
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
- (2016) Magdalena Paolino et al. Cancers
- AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
- (2015) T. M. Brand et al. CLINICAL CANCER RESEARCH
- Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
- (2015) Steven B. Chinn et al. JOURNAL OF CLINICAL ONCOLOGY
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial
- (2014) P. Bossi et al. ANNALS OF ONCOLOGY
- Oral cancer: Current role of radiotherapy and chemotherapy
- (2013) SH. Huang et al. Medicina Oral Patologia Oral y Cirugia Bucal
- VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
- (2012) M. Terme et al. CANCER RESEARCH
- Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
- (2011) K. Toustrup et al. CANCER RESEARCH
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search